These findings collectively suggest that the MTA1-TFAP2C or MTA1-IFI16 complex may be involved in the epigenetic regulation of ESR1 expression, thereby influencing the chemosensitivity of BC tumors to tamoxifen therapy (140). Here, IFI16 is linked to breast cancer.